Sanofi Tells 10th Circ. It Paid $36M To Access EpiPen Market

Sanofi-Aventis US LLC told the Tenth Circuit during oral argument Wednesday that it should not have had to offer a pharmacy benefits manager $36 millionĀ in rebates for an unrelated product to...

Already a subscriber? Click here to view full article